Studies in MS subjects have demonstrated low levels of sex hormones, like estrogen, are associated with higher circulating levels of tumor necrosis factor (TNF) and interferon gamma (IFNγ) [6]. This evidence concerns the gene TNF and myeloid sarcoma.